Related Experiment Video
Updated: Jun 24, 2026

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues
Published on: February 19, 2019
Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation
Govindarajan Rajagopalan1, Ashenafi Y Tilahun, Yan W Asmann
1Department of Immunology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA. rajagopalan.govindarajan@mayo.edu
Abstract:
Toxic shock syndrome (TSS) is an acute, serious systemic illness caused by bacterial superantigens. Nonavailability of a suitable animal model until recently has hampered an in-depth understanding of the pathogenesis of TSS. In the current study, we characterized the early molecular events underlying TSS using our HLA-DR3 transgenic mouse model. Gene expression profiling using DNA microarrays identified a rapid and significant upregulation of several pro- as well as anti-inflammatory mediators, many of which have never been previously described in TSS. In vivo administration of staphylococcal enterotoxin B (SEB) led to an increase in the expression of Th0- (IL-2, 240-fold); Th1- (IFN-gamma, 360-fold; IL-12, 8-fold); Th2- (IL-4, 53-fold; IL-5, 4-fold) as well as Th17-type cytokines (IL-21, 19-fold; IL-17, 5-fold). The immunoregulatory cytokines (IL-6, 700-fold; IL-10, 18-fold); CC chemokines (such as CCL 2, 11, 3, 24, 17, 12, 7), CXC chemokines (such as CXCL 1, 2, 5, 11, 10, 19); and several proteases (matrix metalloproteinases 13, 8, 3, and 9) were also upregulated. Serum levels of several of these cytokines/chemokines were also significantly elevated. Pathway analyses revealed significant modulation in a variety of biochemical and cellular functions, providing molecular insights into the pathogenesis of TSS. Administration of bortezomib, a clinically approved proteasome inhibitor capable of blocking NF-kappaB pathway, was able to significantly modulate the expression of a variety of genes induced by SEB. Thus, our study showed that TSS is a complex process and emphasized the potential of use of bortezomib in the therapy of superantigen-induced TSS.
Insights
Toxic shock syndrome (TSS) involves complex molecular events. This study used a transgenic mouse model to identify early inflammatory responses and potential therapeutic targets like bortezomib for superantigen-induced TSS.
Area of Science:
- Immunology
- Molecular Biology
- Microbiology
Background:
- Toxic shock syndrome (TSS) is a severe systemic illness caused by bacterial superantigens.
- Understanding TSS pathogenesis has been limited by the lack of suitable animal models.
- Early molecular events in TSS require detailed characterization to identify therapeutic targets.
Purpose of the Study:
- To characterize early molecular events in toxic shock syndrome pathogenesis.
- To investigate the efficacy of bortezomib in modulating superantigen-induced gene expression in a mouse model.
Main Methods:
- Utilized a human leukocyte antigen (HLA)-DR3 transgenic mouse model for TSS studies.
- Employed DNA microarrays for gene expression profiling after staphylococcal enterotoxin B (SEB) administration.
- Analyzed serum cytokine and chemokine levels and pathway modulation.
- Assessed the effect of bortezomib on SEB-induced gene expression.
Main Results:
- Identified rapid upregulation of pro- and anti-inflammatory mediators, including Th0, Th1, Th2, and Th17 cytokines, immunoregulatory cytokines, chemokines, and proteases.
- Observed significant elevation in serum levels of several identified cytokines and chemokines.
- Pathway analysis revealed significant modulation of biochemical and cellular functions.
- Bortezomib treatment significantly modulated SEB-induced gene expression, indicating potential therapeutic benefit.
Conclusions:
- Toxic shock syndrome is a complex inflammatory process with a distinct early molecular signature.
- The HLA-DR3 transgenic mouse model is valuable for studying TSS pathogenesis.
- Bortezomib shows potential as a therapeutic agent for superantigen-induced TSS by modulating key inflammatory pathways.
More Related Videos
09:26Identification of Antibacterial Immunity Proteins in Escherichia coli using MALDI-TOF-TOF-MS/MS and Top-Down Proteomic Analysis
Published on: May 23, 2021
08:51Applying an Inducible Expression System to Study Interference of Bacterial Virulence Factors with Intracellular Signaling
Published on: June 25, 2015
Related Concept Videos
Stringent Response in E. coli
Regulation of Bacterial Virulence
Clinical Significance of Antibiotic Resistance
Bacterial Toxins
Gene Regulation in Microbial Communities: Quorum Sensing
Determinants of Bacterial Pathogenicity and Virulence